Biosimilar Savings Calculator
Discover Biosimilar Savings Possibilities
See potential biosimilar savings with our Biosimilar Savings Calculator, which quickly compares current Stelara® costs with biosimilar Otulfi®.
The Biosimilar Difference
With multiple Stelara biosimilars now available, offering up to 96% cost reductions, every month of delay means continued overspend. With our Biosimilar Advantage Formulary, one Serve You Rx client with three Stelara patients uncovered $432,000 in annual savings opportunities. Advantages of switching to a biosimilar-forward formulary include:
Stelara Biosimilar Savings Calculator
Discover potential savings with the Stelara biosimilar, Otulfi.
Annual Savings
$49,760.00 Estimated annual savings per member
Important Considerations
Estimated Costs: Pricing based on rounded estimates for 90mg dose, 4 fills per year.
Rebate Reality: Stelara rebates average around 36% of list price but are not typically available for biosimilars. This calculator uses current market rebate data for Stelara.
Actual Savings: While Stelara net costs (after rebates) may seem competitive, Otulfi offers predictable, transparent pricing without rebate complexity.
Clinical Equivalence: FDA-approved biosimilars have no clinically meaningful differences from Stelara in terms of safety and efficacy.
Copay Assistance: Otulfi pricing includes manufacturer copay assistance programs that can significantly reduce patient out-of-pocket costs.
Stelara Biosimilar Savings Calculator
Discover potential savings with the Stelara biosimilar, Otulfi.
Annual Savings
$49,760.00 Estimated annual savings per member
Important Considerations
Estimated Costs: Pricing based on rounded estimates for 90mg dose, 4 fills per year.
Rebate Reality: Stelara rebates average around 36% of list price but are not typically available for biosimilars. This calculator uses current market rebate data for Stelara.
Actual Savings: While Stelara net costs (after rebates) may seem competitive, Otulfi offers predictable, transparent pricing without rebate complexity.
Clinical Equivalence: FDA-approved biosimilars have no clinically meaningful differences from Stelara in terms of safety and efficacy.
Copay Assistance: Otulfi pricing includes manufacturer copay assistance programs that can significantly reduce patient out-of-pocket costs.
The Biosimilar Difference
With multiple Stelara biosimilars now available, offering up to 96% cost reductions, every month of delay means continued overspend. With our Biosimilar Advantage Formulary, one Serve You Rx client with three Stelara patients uncovered $432,000 in annual savings opportunities. Advantages of switching to a biosimilar-forward formulary include:
See what your clients can save with the Biosimilar Advantage Formulary
Get in touch today for a free repricing analysis to see what your clients could save with our Biosimilar Advantage Formulary.